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1. Introduction 
The pathophysiology of Neuropsychiatric SLE (NPSLE) will be described in this chapter. 
Systemic Lupus Erythematosis (SLE) is a multiorgan and multisystem autoimmune 
disorder and its pathophysiology may have protean effects on all components of the 
nervous system. The central (CNS) and peripheral nervous systems (PNS) may be 
involved in SLE. About 25 % of SLE may begin in childhood and SLE may present both 
steadily chronic and more episodic neurologic symptoms as well throughout the life span. 
The presentation of symptoms and clinical signs is a reflection of the location and type of 
pathophysiology of the disease in which there is chronic inflammation of varied degrees 
that may wax and wane. The chronic disease process is responsible for making the CNS 
for example more vulnerable to lowered seizure threshold and episodic seizures despite 
the ongoing more chronic pathophysiology involving the inflammation of the blood 
vessels. The disease may exert effects on peripheral nerves and over time accumulated 
lesions or immune mediated damage may make tissues more susceptible to damage. 
Chronic inflammation or immune mediated damage or vasculitis of blood vessels or the 
vascular supply of the nerves may predispose to neuropathy and lead to progressive 
deterioration in function over time as lesion burden accumulates in the PNS. Similarly, 
SLE may also damage various end organs that may impact the nervous system once 
affected. For example, SLE may impact the heart and cardiovascular system or be 
associated with antiphospholipid antibodies that may contribute to embolic strokes. Other 
end organs may be affected for example kidney dysfunction or renal failure that may lead to 
uremic encephalopathy. Having a rash present or palpable purpura and multiorgan 
involvement may present clinical clues that SLE is the diagnosis along with clinical 
evidence of multisystem involvement. Other pathophysiology exists as noted below. In 
these regards, this chapter seeks to characterize the pathophysiology of the major 
categories of disease and syndromes on the  nervous system in SLE. The categorization of 
the signs and symptoms and overall disease state and pathophysiology and structures 
involved will relate to how these conditions are ultimately diagnosed and treated. 
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Neurologists need to be aware of the varied presentations of SLE as neurologic symptoms 
may be the first signs or symptoms that come to medical attention for evaluation. 
Unfortunately since SLE results from chronic and indolently progressive 
pathophysiology, often only subtle neurologic signs develop insidiously over years and 
therefore often the diagnosis of SLE may be only possible retrospectively in these regards 
in some cases. 
2. The proposed autoimmune mechanism of SLE on the nervous system and 
resultant effects 
While the definitive mechanisms are unknown, the general principle is that antibodies or 
immune complexes may attack the blood supply to the neural structures. HLA type may 
regulate the susceptibility to SLE. Studies of twins seem to indicate that many other factors 
may work in conjunction with HLA typing to produce clinical disease. Although 
antineuronal antibodies exist, it is unclear how they exert their effects. Over time, it is 
thought that progressive inflammation may lead to progressive decline and dysfunction. 
Recent articles or case reports that delineate that antithyroglobulin antibodies, 
antimicrosomal antibodies, anti cardiolipin antibodies, B2Glycoprotein I antibodies, 
antinuclear antibodies, the presence of lupus anticoagulant, and other antibodies may be 
some of the proposed mediators of immune damage of the CNS. Arguably, much research is 
needed in this area and complete mechanisms are not understood. SLE mediated attack on 
tissues is a diverse one including varied mechanisms of deposition of immune complexes, 
cytokines, and numerous modulators of these activities are postulated to be involved. 
Studies indicate that there may be attack of neural elements or tissues through the 
autoantibodies and activated leukocytes. 
Medications (such as phenytoin) may produce drug induced lupus, which often spares  
the kidneys and CNS. The antibody profile of this entity and general immunology however 
may also differ from non-medication induced SLE. Over time, SLE in the CNS may  
cause demyelination and various demyelinating syndromes or multiple sclerosis like  
illness that may seemingly relapse and remit. Similarly a vasculitis may progress either 
fulminantly or indolently. Multiple yet to be described pathophysiologies may account for 
the varied syndromes noted below. Varied preponderances or ratios of antibody types in 
local tissues may also explain somehow whether or nor there is more central or more 
peripherally mediated neural damage. While the above observations are noted, the 
mechanism of CNS involvement remains unknown since neither the presence of 
antineuronal and antiastrocyte antibodies correlate with any CNS pathology or level of 
involvement. The literature and clinical experience notes that neurological complications 
may be fulminant or fatal. In general, diagnosis is made on a clinical basis although 
laboratory confirmation of positive antinuclear antibodies, anti-DNA, anti-RNA, and low 
complements are supportive in many cases along with identifying other systemic or 
multiorgan involvement. 
3. The importance of the physical and neurological examination: A clinical 
key to pathophysiology 
If SLE or NPSLE is suspected, a careful and detailed meticulous history and physical is 
mandatory. Specific attention to nearly every organ system in the general medical 
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examination may yield clues about the presence of an underlying autoimmune or infiltrative 
or inflammatory disorder. From the moment the patient enters the office, one may notice the 
malar rash or the anterior tibial vasculitic infiltrative leucocytoclastic mediated rash. 
Specifically with regards to the neurologic system, a systematic approach should be used in 
gathering history and examination of mental status, cranial nerves, motor function, reflexes, 
coordination/cerebellar function, as well as sensory function and gait.  Auscultation of the 
carotid and vertebral arteries, the heart, and looking for Lhermitte’s sign and stigmata of 
emboli are mandatory. Because of the infiltrative nature of SLE, CNS manifestations of the 
disease include cognitive dysfunction, headaches, confusion, fatigue, depression, mood 
disorders, demyelinating syndromes, seizures, movement disorders, and strokes. 
Headaches, depression, fatigue, mood disorders, and cognitive disorders are associated with 
SLE but the mechanisms of the pathophysiology producing these exact symptoms or 
syndromes is poorly understood. It is postulated that various degrees of lesion burden in 
various locations on the CNS may be associated with these symptoms. 
In the peripheral nervous system, peripheral nerve damage causing peripheral neuropathy, 
facial pain, tingling, burning, or numbness may occur. Chronic inflammatory diseases may 
cause dysfunction of individual named nerves, usually by interfering with their blood supply, 
thereby causing a mononeuritis or if multiple nerves are involved, a more confluent and 
diffuse or regionalized mononeuritis multiplex may result over time. Of note, SLE itself or 
associated treatments such as with corticosteroids that can cause papilledema or pseudotumor.  
4. Diagnosing CNS lupus and ancillary testing- a window into the 
pathophysiology of neuropsychiatric SLE 
Laboratory testing may give clues about the pathophysiology of NPSLE. Abnormal CSF is 
identified in about 50 % of cases with increased mononuclear cells along with oligoclonal 
bands, and antineuronal antibodies. CT scans and angiograms and MRI scans collectively 
may be unhelpful when there are no focal findings or if there is mild and diffuse disease, 
although MRI is the most sensitive radiologic tool to detect virtually any inflammatory, 
demyelinating, or infiltrative pathology relating to NPSLE. Laboratory markers often do not 
correlate with neurologic disability although high IgG titers of antineuronal antibodies in 
CSF may correlate with diffuse disease or high lesion burden on the nervous system. 
Although 70% of patients may have abnormal electroencephalograms, the findings on the 
EEG are not necessarily diagnostic of NPSLE by these EEG abnormalities themselves. 
NPSLE may mimic demyelinating disease and most often the patient may need evidence of 
multisystem or multiorgan involvement to make the diagnosis. The multiorgan or 
multisystem manifestations according to previously published guidelines include the 
presence of malar rash, a discoid rash, the presence of photosensitivity, oral ulcers, arthritis, 
serositis, renal disease or neurologic or hematologic disorders, or immunologic disorders or 
the presence of antinuclear antibodies. According to these guidelines if four such clinical 
criteria are present at any time during the course of the disease, a diagnosis of SLE may be 
made with 98 % specificity and 97 % sensitivity.  
5. CNS disease: General principles 
NPSLE may involve as many as 75% of SLE cases according to Johnson and Richardson. 
Impaired mentation, consciousness, seizures, cranial neuropathies and derangements of  
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CNS functions may either occur transiently, mildly, or late in the disease as lesion burden 
accumulates. CSF analysis may be basically normal or show only a mild lymphocytic 
pleocytosis with an increased protein. According to some sources, most of the central 
nervous system manifestations can be accounted for the pathophysiology of numerous 
micro infarcts due to the accumulation of lesions in arterioles and capillaries.  
The literature postulates that deposition of immune complexes in the vascular 
endothelium mediates vascular injury and since many patients also have concomitant 
hypertension, this also affects cerebral blood vessels predisposing them to hemorrhage. 
As mentioned above, cardiac injury can predispose to embolic complications of 
endocarditis. Visual complaints are common, especially in children and may include 
retinal artery occlusion, retinal hemorrhage, cotton wool exudates, papilledema and optic 
neuritis. Complications of SLE may lead to hypertensive encephalopathy, cerebral vein 
thrombosis, cranial neuropathies, brainstem dysfunction, and rarely myelopathy. SLE 
may predispose to bacterial or fungal meningitis or opportunistic infection or cause an 
aseptic meningitis. 
6. Pathophysiology of encephalopathy 
Encephalopathy is a general term indicating impaired brain function and this may occur 
with any amount of brain or CNS involvement in NPSLE. Clinically encephalopathies may 
present with confusion, lethargy or coma. Encephalopathies may also present more 
chronically as “brain failure” in which a patient may exhibit dementia or cognitive 
dysfunction. There are both acute and chronic presentations involving psychiatric 
symptoms. The literature notes that in general, patients with neuropsychiatric 
manifestations of SLE in the CNS may have abnormalities on functional neuroimaging and 
MRI suggesting either a disruption of normal blood flow or a dysregulation of normal 
metabolic function.  Encephalopathies may be due to cerebritis. NSAIDS or nonsteroidal 
anti-inflammatory drugs may also contribute to encephalopathy by producing aseptic 
meningitis.  
Since many patients with SLE are on chronic immunosupression, the CNS may be  
infected with opportunistic organisms and result in meningitis, encephalitis, or abscess. 
Medications used for treatment of these entities may also contribute or cause 
encephalopathy.  
Posterior Reversible Encephalopathy Syndrome (PRES) generally occurs in patients with 
uncontrolled hypertension who are on immunosupression therapy. Renal involvement of 
SLE is common with PRES. This syndrome may present as a fulminant encephalopathy 
involving bi-occipital patchy swelling on MRI neuroimaging which has been described in 
the literature. Fortunately with control of the hypertension, clinical and radiologic 
reversibility may occur. The pathophysiology of this condition in NPSLE is unknown but is 
thought to be due to abnormal permeability of blood vessles. 
Brain biopsy may be needed to clarify the pathophysiology when MRI findings cannot 
distinguish cerebritis from another process such as neoplasm like changes or those of 
opportunistic infection. Meningeal biopsy may be needed to diagnose chronic meningitis 
when other methods fail in cases of idiopathic chronic encephalopathies. 
Focal neurological deficits may result from strokes due to either cardioembolic valvular 
disease or fulminant vasculitic changes of the cerebrovasculature, or thrombosis associated 
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with the antiphospholipid antibodies. Dyskinesias may occur and the pathophysiology is 
thought to be due to the effects of the antiphospholipid antibodies.  
7. Pathophysiology of demyelinating disease 
SLE may cause changes in both CNS and PNS myelin. The changes may relapse and 
remit, thereby mimicking attacks of Multiple Sclerosis(MS) like illnesses radiologically 
and clinically. It should be noted that the neuroimmunology of these conditions may 
differ substantially, and that the pathophysiology of both entities and the differences are 
not fully understood. The spectrum of radiological involvement can identify minor and 
non specific white matter changes to more confluent appearing lesions throughout the 
neuraxis. NPSLE pathophysiology may therefore mimic what are termed the clinically 
isolated syndromes of MS such as optic neuritis, transverse myelitis, and more wide 
spread pathology. A Devic-like syndrome in which there is optic neuritis and changes in 
the spinal cord is possible, and Devic’s disease or Neuromyelitis Optica may be 
differentiated by the occurrence of NMO antibodies or the presence of antibodies to 
aquaporin 4 which are noted in Devic’s disease. 
8. The pathophysiology of seizures in NPSLE 
Seizures occur in up to about 25% of patients with NPSLE compared with about 1% in  
the general population. Seizures may present early in the course of NPSLE. While  
focal seizures are postulated to be caused from microinfarcts that damage the cortex, 
systemic derangements and metabolic disturbances and certain medications may cause 
generalized seizures. Seizures are thought to result from cortical injury from cerebral 
vascultis, cardioembolism, or any lesion that may develop within the brain. The presence 
of cortical location and the presence of cortical hemorrhage or blood products generally 
increase the likelihood of seizures. The literature indicates that high dose steroid therapy 
given in pulses is associated with the development of status epilepticus by an unknown 
mechanism. Focal seizures may also become generalized seizures, and virtually  
any seizure type may be seen in SLE. Generalized or multifocal onset seizures are 
common in children with SLE and occur about 10 % of cases. While antiepileptic therapy 
is often prescribed, these medications do not generally treat what is thought to represent 
the underlying pathophysiology as the seizures may relate to ongoing inflammation  
that is somehow contributing to cortical irritability. Nonetheless, many patients are  
often managed in the short term with anti-seizure medications. Some authors suggest  
that anti-epileptic medication should be continued until a normal or benign EEG pattern 
is observed. No study on this however has been performed, and guidelines on how  
long anti-epileptic medication should continue are lacking. It should be noted that a 
benign or normal EEG may be seen in patients who have seizure disorders. EEG or  
EEG monitoring may be useful in patients who may be at risk or have ongoing subclinical 
status epilepticus during a fulminant NPSLE related encephalopathy but it is unknown  
if persistence of status epilepticus correlates with a certain type or subset of ongoing 
pathophsyiology of NPSLE in that circumstance. Treatment using antiseizure medications 
may be useful in an acute setting but these medications do not alter the direct 
pathophysiology of NPSLE. Since multiorgan failure may contribute to encephalopathy, 
electrolyte disturbances, or hypertension, treatment of these entities are necessary to  
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gain control of the seizures that are provoked through those pathophysiologies in  
NPSLE. The author advises caution in diagnosing patients with first time seizures as 
idiopathic and in general such patients ought to be seen in follow up to ensure no other 
systemic or multiorgan involvement may be developing. It may be only in retrospective 
analysis that these patients might be diagnosed with NPSLE. The epidemiology and 
pathophysiology of these cases is unknown although the author has noted the subsequent 
onset of SLE or at least the fulfillment of SLE by clinical criteria over time in several such 
patients. Since NPSLE is a chronic disease, there may also be a need for lifetime 
prophylaxis with anti-seizure medications but trials and definitive guidelines on this are 
lacking, and anecdotally patients with epilepsy and NPSLE may be noted to be best 
controlled in general when the systemic SLE is controlled. 
9. Psychiatric symptoms 
Psychosis is common with NPSLE and steroids may accentuate clinical psychiatric features, 
although an although an associated cognitive disorder may be temporary or progressive. It 
may be difficult to distinguish corticosteroid induced encephalopathies with psychiatric 
symptoms from those of SLE. Since psychiatric symptoms may occur with numerous 
disease states, these symptoms combined with multisystem involvement of SLE are 
especially characteristic and may lead to diagnosis. The pathophysiology is unknown 
although depression and anxiety and psychiatric symptoms may be the initial symptoms of 
NPSLE. Combinations of depression, anxiety, progressive cognitive dysfunction, and 
encephalopathy are thought to be mediated by the previously noted mechanisms of chronic 
inflammation. 
10. Vasculitis 
Vasculitis in NPSLE often becomes a consideration in patient with autoimmune disease and 
in young patients with ischemic or hemorrhagic strokes. Patients often have an 
accompanying encephalopathy, fever, headaches, seizures, and cognitive changes. If there 
are multifocal levels of neurologic dysfunction, malar rash or palpable purpura present, or 
an abnormal urine sediment, then SLE as a clinical diagnosis may be likely.  
Since angiography typically shows irregular beading and caliber changes of large and 
medium branches of the anterior, middle, and posterior cerebral arteries, it is believed that 
the major pathophysiolgy of vasculitis in NPSLE is due to this finding. While angiography 
may be positive, histology often shows degeneration within the walls of the smallest blood 
vessels, while more inflammatory mediators and infiltrates of such are noted in the medium 
and large vessels. Complete understanding of these mechanisms are being studied. There 
may ultimately be both inflammatory and non inflammatory processes involved. Aggressive 
treatment with intravenous steroids and immune modulators are required to treat this often 
fulminantly presenting, fatal or devastating process.  
11. Pathophysiology of ischemic stroke in NPSLE 
Ischemic stroke may result from cardiogenic embolism that is due to nonbacterial or from 
Libman-Sachs endocarditis which occurs on the ventricular or atrial surface of the mitral 
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valve. The presence of antiphospholipid antibodies may also predispose to strokes and 
venous thrombosis as previously noted. Ischemic stroke in NPSLE occurs in children and 
is usually caused by small vessel vascultits. The literature indicates that stroke may occur 
in up to 10 % of pediatric series of NPSLE and occur by mechanisms noted above. 
Thrombotic strokes may present in a more evolving or subacute pattern often with 
premonitory symptoms, and ischemic ones generally present abruptly with deficits 
maximally present at onset.  
Stroke should be clinically distinguished from hemorrhage and other CNS pathologies and 
hemorrhage may be likely in association with cardiac emboli or with cerebral venous 
thrombosis which can also present with seizures. 
12. Pathophysiology of chorea in NPSLE 
Chorea in NPSLE may precede systemic symptoms of SLE by about 1 year as some 
articles indicate and can resolve prior to the evolution of other symptoms or signs. The 
mechanism is unknown. In children, distinguishing this from Sydenham’s chorea may be 
quite difficult since NPSLE may also falsely elevate serum antistreptococcal antibody 
titres which are characteristically seen in Sydenham’s disease. Dopamine blockers such as 
haloperidol or chlorpromazine may be useful as well as aspirin or corticosteroids. The 
diagnosis may be made by finding the presence of lupus anticoagulant or with recurrent 
vascular thrombosis or spontaneous abortions in patients not meeting full criteria for 
diagnosis of SLE. Chorea in pregnancy (Chorea gravidarum) may also be a manifestation 
of NPSLE. A pattern of relapsing and remitting chorea of different intensities may suggest 
NPSLE. 
13. Pathophysiology of fatigue in NPSLE 
This has been described in the literature and it is suggested that many of such patients do 
not have evidence of muscle disease or myopathy. Therefore the mechanism is postulated to 
be due to brain or CNS dysfunction however further details about the pathophysiology is 
unknown. Depression, myopathy, sleep disorder, and systemic disease may need to be 
excluded. The literature indicates that chronic orthostatic hypotension should be excluded 
since this condition also may present with fatigue, although it is not known if infiltration of 
autonomic nerves in NPSLE is the causative pathophysiology which may actually 
predispose to orthostatic hypotension. 
14. Cranial nerve involvement 
Cranial nerve involvement is thought to be rare and transient, generally affecting cranial 
nerve III. Other cranial nerve involvement has been reported and although the mechanism 
of cranial neuropathy in NPSLE in general is not fully understood, the pathophysiology is 
thought to be due to vasculitic changes in the blood supply of the cranial nerves similar to 
that of a mononeuritis multiplex. While involvement of the nuclei or fasicles of the various 
cranial nerves is possible within the brain or brainstem, case series and pathologic correlates 
on this are lacking.  
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15. Pathophysiology of vision and migraine in NPSLE 
The literature indicates that visual and migrainous disturbances occur bilaterally and  
late in the course of SLE. NPSLE is associated with retinal disease, optic neuritis, and 
migraine headaches. While the presence of an acute headache in NPSLE could ultimately 
simply be migraine, it is recommended that one should only make this diagnosis as a 
diagnosis of exclusion since other encephalopathies, opportunistic infections, meningitis  
or cerebritis, or venous thromboses or stroke may also present with headache and may 
occur in SLE.  
16. Spinal cord involvement/myelopathy 
While this is noted to occur, it is thought to occur rarely. Little literature is available. The 
author notes experience with patients who have had a fulminant course of CNS disease 
either from vasculitis or encephalopathy who may also have evidence of myelopathy 
develop. The mechanism on this and its relative rarity is not well understood. The literature 
indicates that spinal involvement and pathophysiology in NPSLE is often functionally 
devastating and may occur acutely, subacutely, or chronically. Syndromes involving a 
transverse myelitis type presentation, infarction, or the identification of a rapidly expanding 
type lesion have been described.  
17. Peripheral nervous system involvement and  
neuromuscular disease 
Peripheral manifestations of NPSLE involve progressive neropathy, myopathy, and diseases 
of the neuromuscular junction(NMJ). NPSLE affecting the NMJ may appear clinically 
similar to myasthenia gravis. Peripheral neuropathy is postulated to be caused by vasculitic 
injury to the blood supply of the nerves- the vasa nervorum – which as noted previously 
produces either a mononeuritis multiplex or a regionalized or more confluent, generalized 
apparent polyneuropathy. SLE may produc peripheral demyelination. Chronic 
demyelination can result in a chronic sensory or sensorimotor polyneuropathy.  SLE acutely 
may exhibit pathophysiology present resembling acute inflammatory demyelinating 
polyradiculoneuropathy or (AIDP) and may mimic Guillian-Barre syndrome. Patients may 
present with burning or numbness sensations, usually starting distally and as disease 
progresses and as lesion burden accumulates on the peripheral nerves, more proximal 
involvement may become evident over time.  
Myopathy may result from the inflammatory cascade and may mimic dermatomyositis or 
polymyositis. One also has to keep in mind that patients diagnosed with SLE may be on 
chronic steroid regimens. The pathophysiology of steroid regimens may contribute to 
muscle fiber atrophy without inflammatory infiltrates. Various medications may also 
contribute to pathophysiology of myopathy in NPSLE.  
Distinguishing between neuromuscular disease and polyradiculopathy may be difficult, and 
EMG, CPK and aldolase testing, and muscle biopsies may be required. CPK/Creatine kinase 
and aldolase may be mildly elevated in SLE myopathy and may not be able to exclude other 
causes of myopathy for example from medications. 
www.intechopen.com
 
The Pathophysiology of Systemic Lupus Erythematosus and the Nervous System 
 
361 
EMG and Nerve conduction studies(NCS) may provide useful clinical data. In  
an inflammatory myopathy which would be expected in cases of NPSLE, the EMG may  
be very active with fibrillations and positive sharp waves and simply may be a marker  
of muscle irritability. There may be increased insertional activity and myopathic motor 
units and recruitment abnormalities noted along with complex repetitive discharges. 
Caution is advised in evaluating patients on treatment for SLE with chronic 
immunosupression or steroids since a normal needle examination on EMG may be 
obtained despite the presence of disease and it is not known how much disease burden is 
required for this testing to be positive. Repetitive stimulation may be useful in evaluating 
neuromuscular junction failure or pathology which is rare but described in NPSLE. NCS 
may identify multiple nerves involved from mononeuritis multiplex, sensory or 
sensorimotor symmetric distal polyneuropathy, or AIDP (Acute Immune-mediated 
Demyelinating Polyradiculopathy). Abnormal F waves and H response abnormalities may 
indicate more proximal root dysfunction.  
Nerve biopsy may be useful in identifying active vasculitis as pathology early in the clinical 
course this may be positive. In more indolent confluent polyneuropathies, there may simply 
be noted nonspecific demyelination. Muscle biopsy may be used to differentiate 
inflammatory from other causes of myopathy.  
Nerve biopsies may identify inflammatory infiltrates, necrotizing vasculitis in epineurial 
arterioles or perivascular infiltrates. Immunoflorescence may be useful in identifying 
immune complexes or complement deposition onto vessel walls. Demyelination or nerve 
fiber count reduction may be noted.  
In Summary, the pathophysiology of NPSLE is complex and mechanisms are at best  
only partly understood. Hopefully in the future, new developments along multiple lines 
will lead to a better understanding of the disease state which could lead to additional 
treatments. 
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